Clinical trial · Observational
Global CALM Implementation Study
Managing Cancer and Living Meaningfully (CALM): A Global Initiative
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study recruitment \& data collection ceased in Dec 2022 in part due to funding shortages and the impact of the COVID-19 Pandemic. 40 clinician-participants consented; 35 completed measures; no data were analyzed or published; REB was closed Nov 2024.
Summary
Brief summary (as posted)
This study seeks to evaluate the implementation of the Managing Cancer and Living Meaningfully (CALM) Program in diverse cultural settings, including its feasibility, fidelity, and acceptability. It will also assess the cross-cultural generalizability of the CALM intervention with a particular focus on patient-reported outcomes with regard to psychological well-being and quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Depression | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Managing Cancer and Living Meaningfully | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Global CALM Training Program Clinicians
- description
- Clinicians engaging in the CALM Training Program.
- interventionNames
- Behavioral: Managing Cancer and Living Meaningfully
Primary outcomes (3)
- measure
- Change in Site Feasibility Metrics
- timeFrame
- Throughout study completion, every 12 months
- description
- The Global CALM Program's site lead will complete site feasibility metrics, which include measures of reach (e.g. # clinicians engaged in CALM training, # of CALM-related research projects), effectiveness (e.g. CALM treatment integrity and supervision evaluation ratings), adoption (e.g. # of patients being seen for CALM), implementation (e.g. # of completed CALM cases, # CALM certified therapists), and maintenance. This measure is completed annually throughout the site's engagement in the CALM Program.
- measure
- Change in Confidence in Therapy - Oncology Questionnaire
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: The research team will approach clinicians who: * have expressed interest in taking part in the Global CALM Program; * able to deliver psychotherapeutic care according to the legislation/organizational policy that regulates their profession; * ≥18 years of age; * able to provide informed consent; * fluent in English (or other language(s) in which training and supervision will be offered); * fluent in the main language spoken in the country where their centre is located (to be able to deliver CALM sessions); and * willing/able to engage with training in the CALM therapy and attend in-person or online supervision meetings (based on feasibility). Exclusion Criteria: \-
References
Publications (0)
Data not yet available